BioCatalystWatch
AGMBWorkspace / AGMB / OverviewCompany library
Agomab Therapeutics NV logo

Agomab Therapeutics NV

Agomab Therapeutics NV (AGMB)

Website

Price
Market cap
Next catalystExpected 2H 2026AGMB-447 — INSPIRIA · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

ALK5 (TGF-β receptor I)

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ALK5 (TGF-β receptor I)

Upcoming / outlook

Other pipelines

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AGMB PR & News

PR & News

AGMB SEC archive